Rapport Therapeutics, Inc. Common Stock (RAPP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.47B
Last updated: Nov 17, 2026 at 4:15 PM ET
Rapport Therapeutics, Inc. Common Stock (RAPP) Stock Chart
Rapport Therapeutics, Inc. Common Stock (RAPP) has a latest price of $23.76 on Nov 17, 2026, 55.1% below its 52-week high of $52.93. Its price fell 2.5% over the past 12 months.
Price Chart
From Jun 2024 to Oct 2026, its highest month-end close was $48.67 in Aug 2026 and its lowest $8.27 in May 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RAPP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RAPP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 51.6%, and over 6 months it fell 30.9%.
| Period | Change |
|---|---|
| 1 month | -16.9% |
| 3 months | -51.6% |
| 6 months | -30.9% |
| 12 months | -2.5% |
| 12 months, with dividends | -2.5% |
Price by Year
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $25.05 | -17.4% |
| 2025 | $30.34 | +71.0% |
Trading Range
The price is 23.5% below its 50-day average of $31.06 and 33.2% below its 200-day average of $35.56.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $23.76 | |
| 52-week high | $52.93 | -55.1% |
| 52-week low | $22.06 | +7.7% |
| 50-day average | $31.06 | -23.5% |
| 200-day average | $35.56 | -33.2% |
Price Risk
Over 3 years, its largest fall from a peak was 75.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.34 |
| Largest fall, 1 year | -57.1% |
| Largest fall, 3 years | -75.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RAPP
What is RAPP's 1-year price change?
Rapport Therapeutics, Inc. Common Stock's price fell 2.5% over the past 12 months. With dividends included, the 12-month total return was -2.5%.
What is RAPP's 52-week high and low?
Rapport Therapeutics, Inc. Common Stock's 52-week high is $52.93 and its 52-week low is $22.06. Its latest price of $23.76 on Nov 17, 2026 is 55.1% below the high.
What is RAPP's beta?
Rapport Therapeutics, Inc. Common Stock's 1-year beta against the S&P 500 is 1.34, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 57.1%.
Is the RAPP chart free?
Yes. Advanced Charting for RAPP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
RAPP pages: Overview, Charting, Earnings, Forecast, Statistics, Competitors